Enfrentando la enfermedad de Alzheimer en los países en desarrollo.
Rev Neuropsiquiatr 80 (2), 2017 (P. 105-110)
Recibido: 03/02/2017 Aceptado: 12/06/2017
PLoS Med 15(7): e1002615. https://doi.org/10.1371/journal. pmed.1002615
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
World Drug Report 2017
-1-
Accessed: 14.03.2019
World Drug Report 2018
-5-
Progress towards targets of the Global action plan on dementia
Published: March 28, 2017https://doi.org/10.1371/journal.pmed.1002271
PLoS Med 14(3): e1002271. https://doi.org/10.1371/journal.pmed.1002271
Attention-Deficit/Hyperactivity Disorder
Arq Neuropsiquiatr 2011;69(2-B):342-348
Identificando o risco de acidente vascular cerebral e melhorando desfechos em pacientes com fibrilação atrial na América Latina
DOI: 10.1590/1516-3180.2015.0222110716
Sao Paulo Med J. 2016; 134(6):534-42
The World Happiness Report 2021 focuses on the effects of COVID-19 and how people all over the world have fared. Our aim was two-fold, first to focus on the effects of COVID-19 on the structure and quality of people’s lives, and second to describe and evaluate how governments all over the world ha...ve dealt with the pandemic. In particular, we try to explain why some countries have done so much better than others.
more
Introduction
Chapter A.4
2017 edition
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
World Drug Report 2018
-4-